Tag: kalvista pharmaceuticals

May 28, 2019

KalVista Pharmaceuticals Presents KVD900 Data

KalVista Pharmaceuticals ( NASDAQ:KALV) has announced it has presented data at he C1 Inhibitor Deficiency and Angioedema Workshop in Budapest,...
December 2, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arsanis Gains 271 Percent

Arsanis, Tyme Technologies, CohBar, Cocrystal Pharma and Contrafect were last week's top gainers.
October 21, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Leads the Pack

MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology...
October 7, 2018

5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent

vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
September 14, 2018

KalVista Pharmaceuticals Reports Fiscal First Quarter Results

KalVista Pharmaceuticals (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,...